Hays James Charles
Known title: DirectorCIK: 0001757909
Hays James Charles's purchase track record
Hays James Charles has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 3/15/2023 | BRO | $268K | +21.1% | +37.4% | +14.8% |
| 5/4/2022 | BRO | $589K | +4.7% | -6.6% | -12.6% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| BRO | ▲ Buy | Open Market | 5,000 | $268K | 3/15/2023 | View on chart |
| BRO | ▲ Buy | Open Market | 5,000 | $295K | 5/5/2022 | View on chart |
| BRO | ▲ Buy | Open Market | 5,000 | $295K | 5/4/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Brown & Brown Faces Mixed Analyst Views on Valuation
Brown & Brown is seeing diverging opinions from Wall Street analysts. Wells Fargo lowered its price target to $68, citing concerns about core business weakness, while TD Cowen initiated coverage with a higher target of $82. The stock currently trades near a key support level, reflecting a market weighing these conflicting assessments of the company's value.
Brown & Brown Faces Mixed Analyst Views on Valuation. Brown & Brown is seeing diverging opinions from Wall Street analysts. Wells Fargo lowered its price target to $68, citing concerns about core business weakness, while TD Cowen initiated coverage with a higher target of $82. The stock currently trades near a key support level, reflecting a market weighing these conflicting assessments of the company's value.